Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
The Lancet Haematology – Extended Anticoagulation in Children with VTE: New Insights from the EINSTEIN-Jr Trial
thelancet.com
Jun 12, 2025, 05:36

The Lancet Haematology – Extended Anticoagulation in Children with VTE: New Insights from the EINSTEIN-Jr Trial

The Lancet Haematology shared on X:

“A cohort study within the EINSTEIN-Jr trial explores extended-phase anticoagulation for acute VTE in children:
  •  Key factors: symptomatic index VTE, unprovoked VTE, & residual thrombosis.
  • Low risk of recurrent VTE & no major bleeding.”

Title: Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.

Autors: Christoph Male, Anthonie W A Lensing, Anthony K C Chan, Gili Kenet, Guy Young, Rukhmi Bhat,  Akos F Pap, Dagmar Kubitza, Martin H Prins, Paul Monagle.

The Lancet Haematology - Extended Anticoagulation in Children with VTE: New Insights from the EINSTEIN-Jr Trial

Here are some of the most compelling recent updates on Hemostasis Today

Akos F Pap Anthonie W A Lensing Anthony K C Chan Anticoagulation Safety Bleeding Risk in Children Christoph Male Dagmar Kubitza EINSTEIN-Jr Trial Extended-phase Anticoagulation Gili Kenet Guy Young Headlines Hemostasis Today Martin H Prins Paul Monagle Pediatric Hemostasis Pediatric Venous Thromboembolism Recurrent Thrombosis Risk Residual Thrombosis Rukhmi Bhat Symptomatic VTE The Lancet Haematology Unprovoked VTE in Children
NewsFeed